1. Home
  2. ALDX vs WEYS Comparison

ALDX vs WEYS Comparison

Compare ALDX & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • WEYS
  • Stock Information
  • Founded
  • ALDX 2004
  • WEYS 1906
  • Country
  • ALDX United States
  • WEYS United States
  • Employees
  • ALDX N/A
  • WEYS N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • WEYS Apparel
  • Sector
  • ALDX Health Care
  • WEYS Consumer Staples
  • Exchange
  • ALDX Nasdaq
  • WEYS Nasdaq
  • Market Cap
  • ALDX 313.4M
  • WEYS 294.5M
  • IPO Year
  • ALDX 2014
  • WEYS N/A
  • Fundamental
  • Price
  • ALDX $5.60
  • WEYS $29.33
  • Analyst Decision
  • ALDX Strong Buy
  • WEYS
  • Analyst Count
  • ALDX 2
  • WEYS 0
  • Target Price
  • ALDX $9.50
  • WEYS N/A
  • AVG Volume (30 Days)
  • ALDX 715.8K
  • WEYS 13.7K
  • Earning Date
  • ALDX 11-06-2025
  • WEYS 11-04-2025
  • Dividend Yield
  • ALDX N/A
  • WEYS 3.71%
  • EPS Growth
  • ALDX N/A
  • WEYS N/A
  • EPS
  • ALDX N/A
  • WEYS 2.69
  • Revenue
  • ALDX N/A
  • WEYS $281,051,000.00
  • Revenue This Year
  • ALDX N/A
  • WEYS N/A
  • Revenue Next Year
  • ALDX $36.23
  • WEYS N/A
  • P/E Ratio
  • ALDX N/A
  • WEYS $10.91
  • Revenue Growth
  • ALDX N/A
  • WEYS N/A
  • 52 Week Low
  • ALDX $1.14
  • WEYS $25.51
  • 52 Week High
  • ALDX $7.20
  • WEYS $41.05
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 59.73
  • WEYS 43.03
  • Support Level
  • ALDX $5.13
  • WEYS $29.61
  • Resistance Level
  • ALDX $5.78
  • WEYS $30.41
  • Average True Range (ATR)
  • ALDX 0.23
  • WEYS 0.91
  • MACD
  • ALDX 0.06
  • WEYS -0.07
  • Stochastic Oscillator
  • ALDX 84.00
  • WEYS 2.25

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: